Position in TSHA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$15,210,816
+$5,102,916 QoQ
Shares Held
2,233,600
+21.5% QoQ
Ownership
0.686%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 208 holders
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TSHA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. TSHA ranks #35 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in TSHA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $15,210,816 | 2,233,600 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $10,107,900 | 1,837,800 | Shares | Sole | 2026-02-10 | |
| 2024-12-31 | $2,527,737 | 1,461,120 | Shares | Sole | 2025-02-12 | |
| 2020-09-30 | $224,000 | 10,000 | Shares | Sole | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||